EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging

M Amin Banihashemi, Saffire H Krance, Patrick Xiang Ji, Morgan Koo, Julie Ottoy, Richard H Swartz, Peter J Kertes, Christopher Hudson, Maged Goubran, Sandra E Black iD

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70884 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von M Amin Banihashemi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Alzheimer Disease, Retina, Brain. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 363 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, CIHR Graduate Scholarships Doctoral Award, Vision Science Research Program Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent studies have highlighted retinal optical coherence tomography (OCT) imaging as a promising biomarker for the early detection of Alzheimer's disease (AD). This review connects AD brain pathology – particularly amyloid beta (Aβ), tau, and vascular changes – with corresponding retinal changes. Evidence suggests that abnormal Aβ and tau deposits in the retina may reflect brain pathology, though their formation mechanisms remain unclear. Retinal vascular changes may also mirror brain pathology, with recent data emerging on other co‐pathologies. Retinal thickness changes, especially in acetylcholine‐producing layers, can differentiate AD from controls, although not in early AD; however, emerging high‐resolution OCT techniques may enhance early detection. We find that correlations between retinal thickness and brain structures are often weak, and retinal vascular imaging shows promise in estimating cerebrovascular disease markers from retinal vascular changes. Novel imaging modalities (e.g., hyperspectral imaging) for detecting retinal Aβ deposits may improve early AD screening when combined with other biomarkers. Highlights Retinal Aβ/tau is equivocal; peripheral retinal p‐tau shows diagnostic promise. OCT retinal/choroid thickness diagnostic/prognostic AUC is small to medium. Hyperspectral imaging and electroretinography may aid early diagnosis. OCTA may differentiate MCI from controls, but preclinical studies are needed. The added value of retinal biomarkers for risk stratification remains uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseRetinaBrainHumansTomography, Optical CoherenceAmyloid beta-Peptidestau ProteinsBiomarkers

Stichwörter der Autor:innen

Alzheimer's diseaseamyloidblood vesselsoptical coherence tomographytau

Substanzen

Amyloid beta-Peptidestau ProteinsBiomarkers

Autor:innen und Institutionen

  • Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
  • Centre for Brain Resilience and Recovery, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada.
  • Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ontario, Canada.
  • School of Public Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
  • Department of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.
  • Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Sandra E Black

Förderung

  • CIHR
  • CIHR Graduate Scholarships Doctoral Award
  • Vision Science Research Program Award
  • Peterborough K.M. Hunter Graduate Scholarship
  • Queen Elizabeth II/Grace Lumsden and Margaret Nicholds Graduate Scholarship in Science & Technology (QEII-GSST)
  • Institute of Medical Science/University of Toronto Open Fellowship Award
  • SCACE Graduate Fellowship in Alzheimer Research
  • Ontario Graduate Scholarship

Zitieren

APA

Banihashemi, M. A., Krance, S. H., Ji, P. X., Koo, M., Ottoy, J., Swartz, R. H., Kertes, P. J., Hudson, C., Goubran, M., & Black, S. E. (2025). Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70884

Vancouver

Banihashemi MA, Krance SH, Ji PX, Koo M, Ottoy J, Swartz RH, et al. Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70884

BibTeX
@article{Banihashemi2025,
  author = {Banihashemi, M Amin and Krance, Saffire H and Ji, Patrick Xiang and Koo, Morgan and Ottoy, Julie and Swartz, Richard H and Kertes, Peter J and Hudson, Christopher and Goubran, Maged and Black, Sandra E},
  title = {Brain and retina in Alzheimer's disease: Pathological intersections and estimates from imaging},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70884}
}
Kostenlos starten →